Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127 JPY | +1.60% | +3.25% | -5.22% |
Business Summary
Number of employees: 38
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio - Successor
92.7
%
| 1,543 | 98.3 % | 2,573 | 92.7 % | +66.72% |
Cellular Therapy
7.3
%
| 26 | 1.7 % | 204 | 7.3 % | +678.95% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 1,569 | 100.0 % | 2,776 | 100.0 % | +76.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yasuo Sakae
ADM | Chief Administrative Officer | - | - |
Director/Board Member | - | - | |
Osamu Sugawara
AUD | Comptroller/Controller/Auditor | 66 | 18-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norikazu Eiki
BRD | Director/Board Member | 76 | 18-05-31 |
Director/Board Member | - | - | |
Aya Chiba
BRD | Director/Board Member | 38 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 39,389,914 | 25,263,124 ( 64.14 %) | 94 ( 0.000239 %) | 64.14 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KIDSWELL BIO CORPORATION 0.00% | 93 | 0.00% | 82 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.22% | 31.32M | |
+13.92% | 118B | |
+12.42% | 106B | |
-4.18% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.19% | 15.56B | |
+3.83% | 13.63B | |
+27.24% | 12.27B |
- Stock Market
- Equities
- 4584 Stock
- Company Kidswell Bio Corporation